Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant
Carl Graham, Jeffrey Seow, Isabella Huettner, et al.
Immunity (2021) Vol. 54, Iss. 6, pp. 1276-1289.e6
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2
Dami A. Collier, Isabella A. T. M. Ferreira, Prasanti Kotagiri, et al.
Nature (2021) Vol. 596, Iss. 7872, pp. 417-422
Open Access | Times Cited: 668
Distinguishing features of current COVID-19 vaccines: knowns and unknowns of antigen presentation and modes of action
Franz X. Heinz, Karin Stiasny
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 339
In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains
Rita E. Chen, Emma S. Winkler, James Brett Case, et al.
Nature (2021) Vol. 596, Iss. 7870, pp. 103-108
Open Access | Times Cited: 251
Mutations and Evolution of the SARS-CoV-2 Spike Protein
Nicholas Magazine, Tianyi Zhang, Yingying Wu, et al.
Viruses (2022) Vol. 14, Iss. 3, pp. 640-640
Open Access | Times Cited: 188
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Ivana Lazarević, Vera Pravica, Danijela Miljanovic, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1192-1192
Open Access | Times Cited: 183
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
David R. Martinez, Alexandra Schäfer, Sarah R. Leist, et al.
Science (2021) Vol. 373, Iss. 6558, pp. 991-998
Open Access | Times Cited: 177
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
Gary R. McLean, Jeremy P. Kamil, Benhur Lee, et al.
mBio (2022) Vol. 13, Iss. 2
Open Access | Times Cited: 174
The humoral response and antibodies against SARS-CoV-2 infection
Hai Qi, Bo Liu, Xinquan Wang, et al.
Nature Immunology (2022) Vol. 23, Iss. 7, pp. 1008-1020
Open Access | Times Cited: 144
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity
Annachiara Rosa, Valerie E. Pye, Carl Graham, et al.
Science Advances (2021) Vol. 7, Iss. 22
Open Access | Times Cited: 131
Antibody and B cell responses to SARS-CoV-2 infection and vaccination
Katharina Röltgen, Scott D. Boyd
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1063-1075
Open Access | Times Cited: 128
Neutralizing antibodies for the prevention and treatment of COVID-19
Lanying Du, Yang Yang, Xiujuan Zhang
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 10, pp. 2293-2306
Open Access | Times Cited: 117
New Coronavirus Variants are Creating More Challenges to Global Healthcare System: A Brief Report on the Current Knowledge
Salsabil Islam, Towhidul Islam, Md. Rabiul Islam
Clinical Pathology (2022) Vol. 15
Open Access | Times Cited: 116
Molecular characteristics, immune evasion, and impact of SARS-CoV-2 variants
Cong Sun, Chu Xie, Guo‐Long Bu, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 113
Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike
Pei Tong, Avneesh Gautam, Ian W. Windsor, et al.
Cell (2021) Vol. 184, Iss. 19, pp. 4969-4980.e15
Open Access | Times Cited: 108
Present variants of concern and variants of interest of severe acute respiratory syndrome coronavirus 2: Their significant mutations in S‐glycoprotein, infectivity, re‐infectivity, immune escape and vaccines activity
Chiranjib Chakraborty, Manojit Bhattacharya, Ashish Ranjan Sharma
Reviews in Medical Virology (2021) Vol. 32, Iss. 2
Open Access | Times Cited: 107
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
Liane Dupont, Luke B. Snell, Carl Graham, et al.
Nature Microbiology (2021) Vol. 6, Iss. 11, pp. 1433-1442
Open Access | Times Cited: 104
A large-scale systematic survey reveals recurring molecular features of public antibody responses to SARS-CoV-2
Yiquan Wang, Meng Yuan, Huibin Lv, et al.
Immunity (2022) Vol. 55, Iss. 6, pp. 1105-1117.e4
Open Access | Times Cited: 85
SARS-CoV-2 S2–targeted vaccination elicits broadly neutralizing antibodies
Kevin W. Ng, Nikhil Faulkner, Katja Finsterbusch, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 655
Open Access | Times Cited: 85
Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein
Valeria Calvaresi, Antoni G. Wrobel, Joanna Toporowska, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 43
The immunology of asymptomatic SARS-CoV-2 infection: what are the key questions?
Rosemary J. Boyton, Daniel M. Altmann
Nature reviews. Immunology (2021) Vol. 21, Iss. 12, pp. 762-768
Open Access | Times Cited: 98
Reduced Magnitude and Durability of Humoral Immune Responses to COVID-19 mRNA Vaccines Among Older Adults
Mark A. Brockman, Francis Mwimanzi, Hope R. Lapointe, et al.
The Journal of Infectious Diseases (2021) Vol. 225, Iss. 7, pp. 1129-1140
Open Access | Times Cited: 91
The success of SARS-CoV-2 vaccines and challenges ahead
Kanta Subbarao
Cell Host & Microbe (2021) Vol. 29, Iss. 7, pp. 1111-1123
Open Access | Times Cited: 87
Overview of Neutralizing Antibodies and Their Potential in COVID-19
José Javier Morales‐Núñez, José Francisco Muñoz‐Valle, Paola Carolina Torres-Hernández, et al.
Vaccines (2021) Vol. 9, Iss. 12, pp. 1376-1376
Open Access | Times Cited: 67
SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies
Ceri A. Fielding, Pragati Sabberwal, James C. Williamson, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 61
N-terminal domain mutations of the spike protein are structurally implicated in epitope recognition in emerging SARS-CoV-2 strains
Apostolos Klinakis, Zoe Cournia, Θεόδωρος Ράμπιας
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 5556-5567
Open Access | Times Cited: 55
Page 1 - Next Page

Scroll to top